Recent developments in Herpes Simplex Virus (HSV-2) therapeutics look promising
In the past two months, new therapies for the prevention and treatment of Herpes Simplex Virus (HSV-2) have showed some promising results. In January, a study published in the New England Journal of Medicine showed More...
Herpes simplex vaccine candidate clinical trial launched
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced the launch of phase 1 clinical trials into an investigational genital herpes vaccine, More...
Advances in herpes prevention and treatment- vaccines and nanoparticles
During the past few days, researchers from Yale University and biotech firm Agenus Inc. have made postive steps toward the prevention, treatment and symptom relief of the sexually transmitted viral infection, herpes More...
